These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15243834)

  • 21. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
    Young WF; McGloin J; Zittleman L; West DR; Westfall JM
    J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose testing and insufficient follow-up of abnormal results: a cohort study.
    Kern LM; Callahan MA; Brillon DJ; Vargas M; Mushlin AI
    BMC Health Serv Res; 2006 Jul; 6():87. PubMed ID: 16836763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical utility of screening of biochemical parameters in elite athletes: analysis of 100 cases.
    Fallon KE
    Br J Sports Med; 2008 May; 42(5):334-7. PubMed ID: 18070805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The results of screening frequency doubling technology perimetry in different locations of the community.
    Mansberger SL; Johnson CA; Cioffi GA
    J Glaucoma; 2007 Jan; 16(1):73-80. PubMed ID: 17224754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a validated clinical case definition of generalized tonic-clonic seizures for use by community-based health care providers.
    Anand K; Jain S; Paul E; Srivastava A; Sahariah SA; Kapoor SK
    Epilepsia; 2005 May; 46(5):743-50. PubMed ID: 15857442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer screening among Latino subgroups in the United States.
    Gorin SS; Heck JE
    Prev Med; 2005 May; 40(5):515-26. PubMed ID: 15749133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study.
    Bishop AJ; Marteau TM; Armstrong D; Chitty LS; Longworth L; Buxton MJ; Berlin C
    BJOG; 2004 Aug; 111(8):775-9. PubMed ID: 15270923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
    Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
    Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of prediction of liver function test abnormalities with the urine urobilinogen and urine bilirubin assays.
    Binder L; Smith D; Kupka T; Nelson B; Glass B; Wainscott M; Haynes J
    Arch Pathol Lab Med; 1989 Jan; 113(1):73-6. PubMed ID: 2642693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tuberculosis control in health care facilities for the elderly, from the viewpoint of risk management].
    Ohmori M; Wada M; Mitarai S; Yanai H; Ito K; Yamauchi Y; Shishido S
    Kekkaku; 2006 Feb; 81(2):71-7. PubMed ID: 16529008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The financial value of services provided by a rural community health fair.
    Dulin MK; Olive KE; Florence JA; Sliger C
    J Health Care Poor Underserved; 2006 Nov; 17(4):821-9. PubMed ID: 17242533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a hepatitis C screening tool in primary care.
    McGinn T; O'Connor-Moore N; Alfandre D; Gardenier D; Wisnivesky J
    Arch Intern Med; 2008 Oct; 168(18):2009-13. PubMed ID: 18852403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.
    Newcombe DA; Humeniuk RE; Ali R
    Drug Alcohol Rev; 2005 May; 24(3):217-26. PubMed ID: 16096125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-channel laboratory testing and the unexpected abnormal result: a statistical myth corrected.
    Phillips WR; Thompson DJ
    N Z Med J; 1981 Dec; 94(698):462-4. PubMed ID: 6950296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which neuromuscular or cognitive test is the optimal screening tool to predict falls in frail community-dwelling older people?
    Shimada H; Suzukawa M; Tiedemann A; Kobayashi K; Yoshida H; Suzuki T
    Gerontology; 2009; 55(5):532-8. PubMed ID: 19776609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Routine" chemistry testing.
    Romm FJ
    Fam Med; 1986; 18(4):230-2. PubMed ID: 3556870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting healthy volunteers in specific populations: a retrospective analysis of clinical and laboratory screening.
    Roux C; Chevassus H; Farret A; Costa F; Petit P; Galtier F
    Fundam Clin Pharmacol; 2010 Feb; 24(1):121-7. PubMed ID: 19686534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.
    Haggerty J; Tudiver F; Brown JB; Herbert C; Ciampi A; Guibert R
    Can Fam Physician; 2005 Dec; 51(12):1658-9. PubMed ID: 16926946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Support of evidence-based guidelines for the annual physical examination: a survey of primary care providers.
    Prochazka AV; Lundahl K; Pearson W; Oboler SK; Anderson RJ
    Arch Intern Med; 2005 Jun; 165(12):1347-52. PubMed ID: 15983282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.